Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
[primary hyperoxaluria type 1]
The
gene
encoding
the
liver
-
specific
peroxisomal
enzyme
alanine
:
glyoxylate
aminotransferase
(
AGT
,
EC
.
2
.
6
.
1
.
44
)
exists
as
two
common
polymorphic
variants
termed
the
"
major
"
and
"
minor
"
alleles
.
The
P
11
L
amino
acid
replacement
encoded
by
the
minor
allele
creates
a
hidden
N-
terminal
mitochondrial
targeting
sequence
,
the
unmasking
of
which
occurs
in
the
hereditary
calcium
oxalate
kidney
stone
disease
primary
hyperoxaluria
type
1
(
PH
1
)
.
This
unmasking
is
due
to
the
additional
presence
of
a
common
disease-
specific
G
170
R
mutation
,
which
is
encoded
by
about
one
third
of
PH
1
alleles
.
The
P
11
L
and
G
170
R
replacements
interact
synergistically
to
reroute
AGT
to
the
mitochondria
where
it
can
not
fulfill
its
metabolic
role
(
i
.
e
.
glyoxylate
detoxification
)
effectively
.
In
the
present
study
,
we
have
reinvestigated
the
consequences
of
the
interaction
between
P
11
L
and
G
170
R
in
stably
transformed
CHO
cells
and
have
studied
for
the
first
time
whether
a
similar
synergism
exists
between
P
11
L
and
three
other
mutations
that
segregate
with
the
minor
allele
(
i
.
e
.
I
244
T
,
F
152
I
,
and
G
41
R
)
.
Our
investigations
show
that
the
latter
three
mutants
are
all
able
to
unmask
the
cryptic
P
11
L
-
generated
mitochondrial
targeting
sequence
and
,
as
a
result
,
all
are
mistargeted
to
the
mitochondria
.
However
,
whereas
the
G
170
R
,
I
244
T
,
and
F
152
I
mutants
are
able
to
form
dimers
and
are
catalytically
active
,
the
G
41
R
mutant
aggregates
and
is
inactive
.
These
studies
open
up
the
possibility
that
all
PH
1
mutations
,
which
segregate
with
the
minor
allele
,
might
also
lead
to
the
peroxisome-
to
-mitochondrion
mistargeting
of
AGT
,
a
suggestion
that
has
important
implications
for
the
development
of
treatment
strategies
for
PH
1
.
Diseases
Validation
Diseases presenting
"common polymorphic variants"
symptom
primary hyperoxaluria type 1
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom